Status:
RECRUITING
Free Fluid Detection With Telementored eFAST
Lead Sponsor:
Oslo University Hospital
Conditions:
Hemoperitoneum
Ascites
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This feasibility study will evaluate the accuracy of telementored eFAST (Extended Focused Assessment with Sonography in Trauma) in detecting abdominal free fluid in patients who have recently undergon...
Detailed Description
The study is designed as a prospective diagnostic trial and involves 40 patients at Oslo University Hospital. Participants will receive an ultrasound examination shortly after surgery, where a nurse ...
Eligibility Criteria
Inclusion
- Patients who have undergone laparoscopic liver surgery at the Oslo university hospital and are within 72 post-surgery
Exclusion
- Allergy to ultrasound gel. Patients colonized with ESBL, MRSA and VRE will be excluded due to infection control. Significant postoperative pain that can exacerbated by probe pressure.
Key Trial Info
Start Date :
June 18 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06594562
Start Date
June 18 2025
End Date
February 1 2026
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo university hospital, Rikshospitalet
Oslo, Oslo County, Norway, 0372